TY - JOUR
T1 - SAGA and SAGA-like SLIK transcriptional coactivators are structurally and biochemically equivalent
AU - Adamus, Klaudia
AU - Reboul, Cyril
AU - Voss, Jarrod
AU - Huang, Cheng
AU - Schittenhelm, Ralf B.
AU - Le, Sarah N.
AU - Ellisdon, Andrew M.
AU - Elmlund, Hans
AU - Boudes, Marion
AU - Elmlund, Dominika
N1 - Funding Information:
Acknowledgments—Anti-Spt7 antibody used in this research was kindly provided by Prof Fred Winston, Harvard Medical School Genetics Department. The authors acknowledge use of instruments and assistance of Dr Hariprasad Venugopal and Dr Simon Crawford at the Monash Ramaciotti Centre for Cryo Electron Microscopy, a Node of Microscopy Australia. This research used equipment funded by Australian Research Council grant LE120100090. We acknowledge the Monash Proteomics and Metabolomics Facility (MPMF) for the provision of technical support and infrastructure, which has been enabled by Bioplatforms Australia (BPA) and the National Collaborative Research Infrastructure Strategy (NCRIS).
Funding Information:
Funding and additional information—H. E. acknowledges the Australian Research Council grant DP170101850 and the National Health and Medical Research Council, Australia, grant APP1125909. C. R. acknowledges Early Career Fellowship (APP1122769).
Publisher Copyright:
© 2021 THE AUTHORS.
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/1
Y1 - 2021/1
N2 - The SAGA-like complex SLIK is a modified version of the Spt- Ada-Gcn5-Acetyltransferase (SAGA) complex. SLIK is formed through C-terminal truncation of the Spt7 SAGAsubunit, causing loss of Spt8, one of the subunits that interacts with the TATAbinding protein (TBP). SLIK and SAGA are both coactivators of RNA polymerase II transcription in yeast, and both SAGA and SLIK perform chromatin modifications. The two complexes have been speculated to uniquely contribute to transcriptional regulation, but their respective contributions are not clear. To investigate, we assayed the chromatinmodifying functions of SAGA and SLIK, revealing identical kinetics on minimal substrates in vitro. We also examined the binding of SAGA and SLIK to TBP and concluded that interestingly, both protein complexes have similar affinity for TBP. Additionally, despite the loss of Spt8 and C-terminus of Spt7 in SLIK,TBPprebound to SLIKis not released in the presence of TATA-box DNA, just like TBP prebound to SAGA. Furthermore, we determined a low-resolution cryo-EM structure of SLIK, revealing a modular architecture identical to SAGA. Finally, we performed a comprehensive study of DNA-binding properties of both coactivators. Purified SAGA and SLIK both associate with ssDNA and dsDNA with high affinity (KD = 10-17 nM), and the binding is sequence-independent. In conclusion, our study shows that the cleavage of Spt7 and the absence of the Spt8 subunit in SLIK neither drive any major conformational differences in its structure comparedwith SAGA, nor significantly affect HAT, DUB, or DNA-binding activities in vitro.
AB - The SAGA-like complex SLIK is a modified version of the Spt- Ada-Gcn5-Acetyltransferase (SAGA) complex. SLIK is formed through C-terminal truncation of the Spt7 SAGAsubunit, causing loss of Spt8, one of the subunits that interacts with the TATAbinding protein (TBP). SLIK and SAGA are both coactivators of RNA polymerase II transcription in yeast, and both SAGA and SLIK perform chromatin modifications. The two complexes have been speculated to uniquely contribute to transcriptional regulation, but their respective contributions are not clear. To investigate, we assayed the chromatinmodifying functions of SAGA and SLIK, revealing identical kinetics on minimal substrates in vitro. We also examined the binding of SAGA and SLIK to TBP and concluded that interestingly, both protein complexes have similar affinity for TBP. Additionally, despite the loss of Spt8 and C-terminus of Spt7 in SLIK,TBPprebound to SLIKis not released in the presence of TATA-box DNA, just like TBP prebound to SAGA. Furthermore, we determined a low-resolution cryo-EM structure of SLIK, revealing a modular architecture identical to SAGA. Finally, we performed a comprehensive study of DNA-binding properties of both coactivators. Purified SAGA and SLIK both associate with ssDNA and dsDNA with high affinity (KD = 10-17 nM), and the binding is sequence-independent. In conclusion, our study shows that the cleavage of Spt7 and the absence of the Spt8 subunit in SLIK neither drive any major conformational differences in its structure comparedwith SAGA, nor significantly affect HAT, DUB, or DNA-binding activities in vitro.
UR - http://www.scopus.com/inward/record.url?scp=85105946404&partnerID=8YFLogxK
U2 - 10.1016/j.jbc.2021.100671
DO - 10.1016/j.jbc.2021.100671
M3 - Article
C2 - 33864814
AN - SCOPUS:85105946404
SN - 0021-9258
VL - 296
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
M1 - 100671
ER -